Novavax Says US Regulator Fast-Tracking Its COVID-19 Vaccine for Clinical Review

Sumary of Novavax Says US Regulator Fast-Tracking Its COVID-19 Vaccine for Clinical Review:

• “The FDA decision to grant Fast Track Designation for NVX-CoV2373 reflects the urgent need for a safe and effective vaccine to prevent COVID-19, and we look forward to working closely with the agency to accelerate access to this vaccine”, Gregory M….

Want to know more click here go to health news source.

From Sputnik - November 9, 2020May 9, 2021